Effect of intravenous acetaminophen on postoperative pain and recovery of patients with brain tumor

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400081710

Enrollment

Unknown

Registered

2024-03-10

Start date

2024-03-10

Completion date

Unknown

Last updated

2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain tumor surgery

Interventions

Control group:None

Acetaminophen group:An additional 0.5g intravenous infusion of acetaminophen was administered 30 minutes before and 30 minutes before the end of surgery

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 18-65 years old; ASA Grade I - III; Patients undergoing craniotomy for resection of brain tumor under elective general anesthesia.

Exclusion criteria

Exclusion criteria: (1) previous cognitive impairment, Alzheimer's disease and other diseases; (2) serious dysfunction of heart, liver, lung, kidney and other organs; (3) hypersensitivity to acetaminophen mannitol; (4) Unable to cooperate with questionnaire investigators; (5) Refuse to participate in this researcher.

Design outcomes

Primary

Measure	Time frame
VAS;Analgesic consumption;	—

Secondary

Measure	Time frame
MMSE;AIS;QoR-15;	—

Countries

China

Contacts

Public ContactChen Jing

The First Affiliated Hospital of Guangxi Medical University

352880721@qq.com+86 136 0781 5280

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026